Journal
JOURNAL OF THORACIC ONCOLOGY
Volume 9, Issue 9, Pages S119-S124Publisher
ELSEVIER SCIENCE INC
DOI: 10.1097/JTO.0000000000000296
Keywords
Thymic neoplasm; International Thymic Malignancy Interest Group; Response measurement
Categories
Ask authors/readers for more resources
Measuring tumor response to chemotherapy is important for both clinical decision-making and for multi-institutional studies. Thymoma tends to spread along the pleura: a challenge for accurate tumor measurement. Inaccurate and inconsistent tumor measurements often compromise results from clinical trials that are dependent on identifying response rate and progression-free survival. In this article, we sought to provide a practical guide on how to measure thymoma by the International Thymic Malignancy Interest Group's recommendations for standard outcome measures. The aim of this article is to clarify this measuring technique, lead to consistency between institutions, and minimize intra- and interobserver variability.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available